Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 30, 2015
Alternative splicing-regulated protein of hepatitis B virus hacks the TNF-α-stimulated signaling pathways and limits the extent of liver inflammation
Jonathan G Pol, Bouchra Lekbaby, François Redelsperger, et al.
Methods in Cell Biology
|
September 10, 2025
Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in mice
Sarah Adriana Scuderi, Fatima Domenica Elisa De Palma, Deborah Mannino, et al.
Journal for Immunotherapy of Cancer
|
August 15, 2020
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
Jonathan G Pol, Matthew J Atherton, Kyle B Stephenson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 11, 2013
Maraba virus as a potent oncolytic vaccine vector
Jonathan G Pol, Liang Zhang, Byram W Bridle, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2023
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
Shuai Zhang, Liwei Zhao, Mengfei Guo, et al.
Oncoimmunology
|
October 25, 2019
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
Sarah Lévesque, Julie Le Naour, Federico Pietrocola, et al.
Oncoimmunology
|
December 8, 2018
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
Jonathan G Pol, Sarah Lévesque, Samuel T Workenhe, et al.
Autophagy
|
June 18, 2025
Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors
Lucille Ferret, Jonathan G Pol, Allan Sauvat, et al.
Oncoimmunology
|
July 26, 2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
Julie Le Naour, Léa Montégut, Yuhong Pan, et al.
Oncolytic Virotherapy
|
December 13, 2018
Development and applications of oncolytic Maraba virus vaccines
Jonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 30, 2015
Alternative splicing-regulated protein of hepatitis B virus hacks the TNF-α-stimulated signaling pathways and limits the extent of liver inflammation
Jonathan G Pol, Bouchra Lekbaby, François Redelsperger, et al.
Methods in Cell Biology
|
September 10, 2025
Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in mice
Sarah Adriana Scuderi, Fatima Domenica Elisa De Palma, Deborah Mannino, et al.
Journal for Immunotherapy of Cancer
|
August 15, 2020
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
Jonathan G Pol, Matthew J Atherton, Kyle B Stephenson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 11, 2013
Maraba virus as a potent oncolytic vaccine vector
Jonathan G Pol, Liang Zhang, Byram W Bridle, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2023
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
Shuai Zhang, Liwei Zhao, Mengfei Guo, et al.
Oncoimmunology
|
October 25, 2019
A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice
Sarah Lévesque, Julie Le Naour, Federico Pietrocola, et al.
Oncoimmunology
|
December 8, 2018
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
Jonathan G Pol, Sarah Lévesque, Samuel T Workenhe, et al.
Autophagy
|
June 18, 2025
Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors
Lucille Ferret, Jonathan G Pol, Allan Sauvat, et al.
Oncoimmunology
|
July 26, 2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
Julie Le Naour, Léa Montégut, Yuhong Pan, et al.
Oncolytic Virotherapy
|
December 13, 2018
Development and applications of oncolytic Maraba virus vaccines
Jonathan G Pol, Matthew J Atherton, Byram W Bridle, et al.
Page
of 6